We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Aventis Loses Second Lovenox Patent Reissuance Bid

Law360 (July 27, 2004, 12:00 AM EDT) -- French drug maker Aventis SA has vowed to continue fighting for a reissuance of a patent for its best-selling anti-blood clotting drug Lovenox, even though its application was rejected twice by...
To view the full article, register now.